Opus Genetics Statistics

Total Valuation

Opus Genetics has a market cap or net worth of $156.55 million. The enterprise value is $126.80 million.

Market Cap	156.55M
Enterprise Value	126.80M

Important Dates

The last earnings date was Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Opus Genetics has 68.96 million shares outstanding. The number of shares has increased by 99.64% in one year.

Current Share Class	68.96M
Shares Outstanding	68.96M
Shares Change (YoY)	+99.64%
Shares Change (QoQ)	+11.46%
Owned by Insiders (%)	14.59%
Owned by Institutions (%)	35.12%
Float	37.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.70
Forward PS	9.13
PB Ratio	24.55
P/TBV Ratio	26.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.23, with a Debt / Equity ratio of 0.18.

Current Ratio	1.23
Quick Ratio	1.21
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-546.69

Financial Efficiency

Return on equity (ROE) is -338.75% and return on invested capital (ROIC) is -112.42%.

Return on Equity (ROE)	-338.75%
Return on Assets (ROA)	-60.73%
Return on Invested Capital (ROIC)	-112.42%
Return on Capital Employed (ROCE)	-528.43%
Revenue Per Employee	$812,944
Profits Per Employee	-$3.79M
Employee Count	18
Asset Turnover	0.38
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +89.17% in the last 52 weeks. The beta is 0.42, so Opus Genetics's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	+89.17%
50-Day Moving Average	1.98
200-Day Moving Average	1.29
Relative Strength Index (RSI)	64.56
Average Volume (20 Days)	411,529

Short Selling Information

The latest short interest is 386,397, so 0.56% of the outstanding shares have been sold short.

Short Interest	386,397
Short Previous Month	499,215
Short % of Shares Out	0.56%
Short % of Float	1.02%
Short Ratio (days to cover)	0.73

Income Statement

In the last 12 months, Opus Genetics had revenue of $14.63 million and -$68.20 million in losses. Loss per share was -$1.37.

Revenue	14.63M
Gross Profit	-12.79M
Operating Income	-37.18M
Pretax Income	-68.20M
Net Income	-68.20M
EBITDA	-37.13M
EBIT	-37.18M
Loss Per Share	-$1.37

Full Income Statement

Balance Sheet

The company has $30.82 million in cash and $1.07 million in debt, giving a net cash position of $29.75 million or $0.43 per share.

Cash & Cash Equivalents	30.82M
Total Debt	1.07M
Net Cash	29.75M
Net Cash Per Share	$0.43
Equity (Book Value)	5.97M
Book Value Per Share	0.09
Working Capital	6.82M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-32.86M
Capital Expenditures	n/a
Free Cash Flow	-32.86M
FCF Per Share	-$0.48

Full Cash Flow Statement

Margins

Gross Margin	-87.37%
Operating Margin	-254.05%
Pretax Margin	-466.09%
Profit Margin	n/a
EBITDA Margin	-253.74%
EBIT Margin	-254.05%
FCF Margin	n/a

Dividends & Yields

Opus Genetics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-99.64%
Shareholder Yield	-99.64%
Earnings Yield	-43.57%
FCF Yield	-20.99%

Analyst Forecast

The average price target for Opus Genetics is $7.17, which is 215.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.17
Price Target Difference	215.86%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	46.16%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Opus Genetics has an Altman Z-Score of -8.45 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.45
Piotroski F-Score	3